ALIM - Alimera Sciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
34.99M
Enterprise Value 3
97.66M
Trailing P/E
N/A
Forward P/E 1
-5.78
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.67
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
1.88
Enterprise Value/EBITDA 6
-29.14

Trading Information

Stock Price History

Beta (5Y Monthly) 2.11
52-Week Change 3719.05%
S&P500 52-Week Change 325.98%
52 Week High 39.98
52 Week Low 30.00
50-Day Moving Average 37.37
200-Day Moving Average 32.72

Share Statistics

Avg Vol (3 month) 3278.77k
Avg Vol (10 day) 375.57k
Shares Outstanding 54.96M
Float 2.59M
% Held by Insiders 116.27%
% Held by Institutions 166.11%
Shares Short (Dec 30, 2019) 474.09k
Short Ratio (Dec 30, 2019) 41.12
Short % of Float (Dec 30, 2019) 42.17%
Short % of Shares Outstanding (Dec 30, 2019) 41.49%
Shares Short (prior month Nov 28, 2019) 484.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Nov 14, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -23.40%
Operating Margin (ttm)-11.58%

Management Effectiveness

Return on Assets (ttm)-7.69%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)52.08M
Revenue Per Share (ttm)11.05
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)42.29M
EBITDA -3.35M
Net Income Avi to Common (ttm)-12.02M
Diluted EPS (ttm)-2.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.9M
Total Cash Per Share (mrq)1.59
Total Debt (mrq)40.23M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.98
Book Value Per Share (mrq)-7.78

Cash Flow Statement

Operating Cash Flow (ttm)-3.91M
Levered Free Cash Flow (ttm)781k